Article ID Journal Published Year Pages File Type
7518808 Journal of Clinical Epidemiology 2018 6 Pages PDF
Abstract
In the setting of febrile neutropenia, re-randomization increased recruitment while providing similar estimates of treatment effect to parallel group trials, with minimal loss to follow-up or non-compliance. It appears to be safe and efficient alternative to parallel group designs in this setting.
Related Topics
Health Sciences Medicine and Dentistry Public Health and Health Policy
Authors
, , , , , ,